- Home
- CSTE vs VXRT Comparison
CSTE vs VXRT Comparison
Compare CSTE & VXRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSTE
- VXRT
- Stock Information
- Founded
- CSTE 1987
- VXRT N/A
- Country
- CSTE Israel
- VXRT United States
- Employees
- CSTE N/A
- VXRT N/A
- Industry
- CSTE Building Materials
- VXRT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CSTE Industrials
- VXRT Health Care
- Exchange
- CSTE Nasdaq
- VXRT Nasdaq
- Market Cap
- CSTE 105.4M
- VXRT 119.0M
- IPO Year
- CSTE 2012
- VXRT N/A
- Fundamental
- Price
- CSTE $2.21
- VXRT $0.41
- Analyst Decision
- CSTE Strong Buy
- VXRT Strong Buy
- Analyst Count
- CSTE 1
- VXRT 2
- Target Price
- CSTE $6.00
- VXRT $3.00
- AVG Volume (30 Days)
- CSTE 98.2K
- VXRT 1.5M
- Earning Date
- CSTE 05-07-2025
- VXRT 05-13-2025
- Dividend Yield
- CSTE N/A
- VXRT N/A
- EPS Growth
- CSTE N/A
- VXRT N/A
- EPS
- CSTE N/A
- VXRT N/A
- Revenue
- CSTE $424,487,000.00
- VXRT $28,700,000.00
- Revenue This Year
- CSTE N/A
- VXRT N/A
- Revenue Next Year
- CSTE $6.56
- VXRT N/A
- P/E Ratio
- CSTE N/A
- VXRT N/A
- Revenue Growth
- CSTE N/A
- VXRT 288.94
- 52 Week Low
- CSTE $2.20
- VXRT $0.28
- 52 Week High
- CSTE $6.55
- VXRT $1.07
- Technical
- Relative Strength Index (RSI)
- CSTE 31.94
- VXRT 50.08
- Support Level
- CSTE $2.47
- VXRT $0.37
- Resistance Level
- CSTE $2.62
- VXRT $0.38
- Average True Range (ATR)
- CSTE 0.17
- VXRT 0.04
- MACD
- CSTE -0.05
- VXRT 0.01
- Stochastic Oscillator
- CSTE 0.54
- VXRT 57.06
About CSTE Caesarstone Ltd.
Caesarstone Ltd manufactures engineered quartz surfaces. Its products include engineered quartz and porcelain slabs, which are used as kitchen countertops in renovation and remodeling, and residential construction. It also has other applications, including vanity tops, wall panels, backsplashes, floor tiles, stairs, and other interior surfaces that are used in various residential and non-residential applications. The company sells its products under the Caesarstone brand. Caesarstone's geographical segments are the United States, Canada, Latin America, Australia, Asia, Israel, and EMEA(Europe, Middle East, Africa).
About VXRT Vaxart Inc
Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.